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Summary
Background Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but 
no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence 
and circulation of Zika virus in Angola.
Methods Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance 
were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigação em Saúde (Ministry of 
Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, 
we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate 
Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse 
transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate 
the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays 
were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection. 
Findings Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected 
microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or 
chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription 
PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral 
genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between 
July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued 
until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities 
consistent with congenital Zika syndrome and serological evidence for Zika virus infection. 
Interpretation Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place 
in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is 
crucial.
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Introduction
Zika virus is an RNA virus of the Flavivirus genus that is 
primarily transmitted by Aedes spp mosquitoes. It is 
classified into two distinct lineages, the African and the 
Asian genotypes. Serological studies suggest that Zika 
virus might be widespread across Africa,1 but serological 
assays are difficult to interpret because of extensive cross-
reactivity among related flaviviruses.2 Before 2007, the 
virus had been identified in only 14 humans in Africa and 
Asia,3 and infection was thought to cause only mild 
symptoms, including fever, headache, and rash.1 However, 
since 2013, the Asian genotype of Zika virus has spread to 
locations in the Pacific and the Americas, resulting in 
more than 800 000 suspected and confirmed cases of 
disease.4 The discovery that infection with Zika virus 
during pregnancy can cause severe birth defects and other 
adverse outcomes2 prompted a research response that, to 
date, has been focused largely on the Pacific and the 
Americas.
Hundreds of millions of people in sub-Saharan Africa 
live in areas with competent mosquito vectors and appro-
priate climatic conditions that render them susceptible to 
infection with Zika virus.5 Despite the potential for 
widespread circulation, data for transmission of the virus 
in Africa are scarce. Three African countries (Angola, 
Cape Verde, and Guinea-Bissau) have reported suspected 
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human cases of Zika virus and clusters of suspected 
microcephaly cases since 2015.6–9 Only the cases in Angola 
and Cape Verde are thought to have been caused by the 
Asian lineage virus.6,10–12 Understanding these outbreaks is 
crucial for safeguarding public health in Africa and 
elsewhere.
Obtaining accurate surveillance data for Zika virus is 
challenging because most cases are asymptomatic, symp-
toms (when present) are mild and non-specific, and 
infections are frequently misclassified.2 In the absence of 
appropriate surveillance data, phylogenetic analyses of 
viral genome sequences have proven important in tracing 
the origins and transmission of outbreaks.13–17 The lack of 
Zika virus genomes from Africa hinders understanding 
of the re-emergence of the virus on the continent.
In this study, we aimed to investigate the outbreak of 
Zika virus in Angola. Because surveillance data from 
Angola are scarce, we considered multiple data streams 
(surveillance data, genomic data, and human mobility 
data) that together provide a more complete picture of the 
outbreak than would be possible had we used any one data 
type alone. Our goal was to provide the first cohesive 
insight into the introduction, circulation, and possible 
public health effects of Zika virus in Angola.
Methods
Overview
We did a multi-component investigation into Zika virus 
and suspected microcephaly cases in Angola. We assessed 
surveillance data from the Ministry of Health in Angola to 
identify acute cases of Zika virus infection confirmed by 
real-time reverse transcription PCR (RT-PCR) between 
December, 2016, and October, 2018. To identify additional 
real-time RT-PCR samples positive for Zika virus that are 
appropriate for sequencing, we also screened samples 
from 349 people with HIV living in Luanda, Angola, in 
2017. We sequenced Zika virus from three samples and did 
phylogenetic analysis to elucidate the origins and duration 
of the Angolan outbreak. We analysed human air travel 
and data on the global incidence of Zika virus infection to 
support our findings about the geographical source of the 
introduced strain. Finally, we assessed suspected cases of 
microcephaly notified to the Ministry of Health in Angola, 
including an extensive clinical and serological investiga-
tion into one case and sequencing of the Zika virus 
genome from a second (previously identified) case.10 
Suveillance for Zika virus in symptomatic, acutely 
infected cases
The Instituto Nacional de Investigação em Saúde (Ministry 
of Health, Luanda, Angola) tests cases of suspected acute 
Zika virus, chikungunya virus, and dengue virus infection. 
Routine surveillance and diagnostic testing of suspected 
cases of acute arboviral infections were initiated in late 
December, 2016. Guidance issued by the Ministry of 
Health suggests that patients should be suspected of acute 
Zika virus infection if they present with fever (that cannot 
be explained by the presence of malaria), conjunctivitis, 
rash, or arthralgia. Clinical guidance in Angola suggests 
that patients are suspected of acute infection with dengue 
Research in context
Evidence before this study
We searched PubMed with the keywords “Zika” and “Africa” 
for papers published in any language up to Oct 31, 2018. 
We also checked available Situation Report publications from 
WHO up to the same date for evidence of Zika virus or 
congenital Zika disease in Africa. The African lineage of Zika 
virus has been detected in Africa since the mid 20th century, 
yet evidence for spread of the Asian lineage of the virus is 
scarce. Two countries in Africa (Cape Verde and Angola) 
have reported cases of Zika virus infection that are thought to 
have been caused by a newly introduced Asian lineage virus. 
Sequence data are crucial to confirm and understand the spread 
of Asian lineage Zika virus in Africa, but these data are currently 
limited to a single 193 bp fragment of the Zika virus NS5 gene 
from Angola. Additionally, although epidemiological data for 
Zika virus and suspected microcephaly cases in Cape Verde have 
been reported in detail, data from Angola are extremely scarce.
Added value of this study
We sequenced Zika virus genomes from three acutely infected 
cases, including one baby with confirmed microcephaly. 
These sequences represent the first three Asian lineage 
genomes available from Africa. Sequence analysis suggested 
that Zika virus was probably introduced from Brazil to Angola 
between July, 2015, and June, 2016, and then circulated 
for at least 17 months. Our study provides the first genomic 
confirmation of autochthonous transmission of the Asian 
lineage of Zika virus within Africa. We also report the second 
confirmed case of Zika-virus-associated microcephaly in 
Angola. Our analyses from Angola improve understanding of 
the extent and clinical effect of Asian lineage Zika virus in Africa.
Implications of all the available evidence
The circulation of the Asian lineage of Zika virus in Angola is 
concerning because of the potential for continued viral spread 
across Africa. Evidence suggests that Zika virus has circulated 
and caused microcephaly in Angola and Cape Verde. Detection 
of additional transmission based on clinical data for suspected 
cases of microcephaly or clusters of mild illness could be 
challenging in countries where systems for reporting birth 
defects are limited and the burden of infectious disease is high. 
Further spread of the Asian lineage of Zika virus is not likely to 
be detected unless routine molecular surveillance systems are 
implemented. Implementation of such a surveillance system is 
especially important in countries that are linked by high human 
mobility to areas that have experienced recent outbreaks of 
Zika virus.
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virus if they have acute fever (2–7 days’ duration), plus at 
least two of headache, retro-orbital pain, myalgia, 
arthralgia, exan thema, leucopenia, or haemorrhagic signs. 
Chikun gunya virus infection is suspected if patients have 
acute fever and unexplained severe arthralgia or arthritis.
Molecular genetic testing for Zika virus
Serum samples were collected in public health facilities 
throughout Angola and then transported to the Instituto 
Nacional de Investigação em Saúde (Luanda, Angola) for 
centralised real-time RT-PCR (appendix p 4). Viral RNA 
was extracted using QiaAmp Viral RNA Mini Kits 
(Qiagen, Germany). Real-time RT-PCR testing for the 
presence of Zika virus, dengue virus, and chikungunya 
virus RNA was done with the US Centers for Disease 
Control (CDC) Trioplex kits18 on an Applied Biosystems 
7500 Fast machine (Thermofisher Scientific, USA).
Screening for additional Zika virus-positive samples
To find more samples positive for Zika virus that would be 
appropriate for Zika virus genomic sequencing, we sought 
additional samples for real-time RT-PCR screening that 
were collected between December, 2016, and October, 2017 
(ie, when confirmed cases of Zika virus were identified in 
Angola), and stored at –80°C since sample collection. An 
appropriate sample set was identified at the Instituto 
Nacional de Luta Contra SIDA (Luanda, Angola). These 
samples were collected between April and November, 2017 
as part of a separate study investigating antiviral drug 
resistance among patients with HIV. Participants in this 
study provided written informed consent for their samples 
to be used in sub sequent studies. No attempt was made to 
select a demographically representative sample set. We 
tested these samples for Zika virus with Bio-Manguinhos 
ZDC real-time RT-PCR kits (Rio de Janeiro, Brazil) on an 
Applied Biosystems 7500 Fast machine. 
Zika virus genome sequencing
Sequencing of the Zika virus genome of all positive real-
time RT-PCR samples was attempted at Instituto Nacional 
de Investigação em Saúde with an Oxford Nanopore 
MinION (Oxford, UK) device per previously published 
protocols.19 A consensus sequence was generated with a 
previ ously published and validated bioinformatics pipeline 
(appendix p 5).19 Four positive real-time RT-PCR samples 
were identified in Angola (one sample from the HIV study 
and three identified from acute cases by the Ministry of 
Health) but biological material was only available from 
three. Of these, two samples could be successfully amplified 
with the attempted whole-genome multiplex PCR.
For genomic sequencing of samples identified in Angola 
that were positive for Zika virus, we used residual samples 
without informed consent but with the approval of the 
Ethical Review Board at the Angolan Ministry of Health. 
Specifically, residual anonymised clinical diagnostic 
samples, with no or minimal risk to patients, were 
provided for research and surveillance purposes within the 
terms of the Parecer Comité de Ética 06 Julho 2017 (National 
Ethics Committee, Ministry of Health, Angola).
While investigations in Angola were underway, Zika 
virus RNA was detected in the urine of a neonate with 
microcephaly born in Portugal in October, 2017, to a 
resident of Angola. Details of this case and the appropriate 
consent and ethical approval have been described 
elsewhere.10 We attempted to sequence the Zika virus 
genome from that case at the Instituto Nacional de Saúde 
Doutor Ricardo Jorge, Águas de Moura, Portugal. 
Therefore, a total of three Zika virus genomes were 
sequenced during this study. 
Phylogenetic analyses
We did phylogenetic analyses to explore the probable 
geographical and temporal origins of the Zika virus 
outbreak in Angola, and the minimal duration of local 
transmission. We used Muscle to align the three new 
Zika virus genomic sequences with 390 other viral 
genomes publicly available from GenBank.20 We used 
PhyML (version 3.1) to estimate maxi mum likelihood 
phylogenies21 and BEAST (version 1.10.3) to estimate 
molecular clock phylogenies (appendix p 5).22
Origins of Angolan Zika virus outbreak
An outbreak of Zika virus infection was reported in 
Cape Verde in 2015–16, from which no genetic sequence 
data are available.7 The absence of genetic data from 
locations that have reported Zika virus and are connected 
to Angola by air travel meant that we could not 
unambiguously infer the geographical origin of the 
Angolan outbreak with phylogenetic analysis alone. We 
therefore analysed the global incidence of Zika virus 
infection and human mobility data to independently 
investigate the probable source of Zika virus in Angola. 
Two factors were considered here as contributing to a 
high risk of exporting the virus to Angola: a high local 
incidence of Zika virus and high numbers of air 
passengers travelling to Angola. The monthly number of 
passengers to Angola from countries reporting Zika 
virus was estimated on the basis of worldwide ticket sales 
data from the International Air Transport Association for 
Jan 1, 2015, to Dec 31, 2017.23 The average Zika virus 
incidence per person per week in each country was 
estimated from surveillance data for the number of 
suspected and confirmed cases of Zika virus infection 
per epidemio logical week (appendix p 6).7,24
Surveillance for suspected microcephaly in Angola and 
association with Zika virus
From Jan 1, 2018, health providers in Angola were 
required to notify the Angolan Direcção Nacional de 
Saúde Pública of infants with suspected microcephaly 
(previously, notifica tion of the Ministry of Health was at 
clinicians’ discretion), and official notification forms were 
issued. Per guidelines from the Direcção Nacional de 
Saúde Pública, micro cephaly should be suspected in male 
See Online for appendix
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neonates with head circumference of less than 32 cm and 
in female neonates with head circumference of less than 
31·5 cm, irrespective of gestational age. These measures 
are equivalent to two SDs below the median head 
circumference expected for a full-term birth.25 Limited 
coverage of health surveillance across Angola meant that 
some infants were identified months after birth. In these 
circumstances, suspected cases of microcephaly were 
identified on the basis of clinical judgment alone.26 We 
considered all reported cases of suspected microcephaly 
from whom serum samples were taken, irrespective of 
whether head circumference was recorded. Thus, all 
cases identified in Angola that are included in this report 
are suspected but unconfirmed. Serum samples were 
also collected from some mothers of suspected cases of 
microcephaly, at the clinicians’ discretion.
Serum samples from suspected cases of microcephaly 
and mothers of suspected cases were tested for Zika virus, 
dengue virus, and chikungunya virus by real-time RT-PCR, 
irrespective of the time between the birth and sample 
collection, according to the same protocols used for other 
samples.
Serum samples from eight infants with suspected 
microcephaly were also tested with the ViDAS ToRC panel 
(BIOMERIEUX, France) for sero logical responses to 
toxoplasmosis, rubella, and cytomegalovirus. The eight 
infants were randomly chosen from early cases where 
samples were taken more than 6 days after delivery. 
Only eight samples were tested due to limited reagent 
availability.
Serological diagnosis of exposure to Zika virus could 
not be done in Angola because ELISAs frequently do not 
accurately discriminate between previous exposure to 
dengue virus and previous exposure to Zika virus and 
facilities for conducting more specific tests were 
unavailable.27
Clinical and serological investigation into a 
microcephaly case identified in Brazil
We were able to do additional follow-up and confirmation 
of one suspected case of microcephaly because the girl 
was identified in Brazil, where a specific serological 
assay, the plaque reduction neutralisation test, and brain 
CT and MRI could be done. She was born in Moxico 
province, Angola, in August, 2017. In November, 2018, 
she travelled with her mother to the Microcephaly 
Reference Centre IPESQ (Campina Grande, Brazil), 
where microcephaly was diagnosed. Before 
November, 2018, neither the child nor her mother had 
travelled outside Angola. Plasma samples were taken 
from both on Nov 30, 2018, and tested for Zika virus and 
dengue virus infection with the EuroImmun IgG ELISA 
(London, UK). A plaque reduction neutralisation test was 
done according to standard protocols (appendix p 4) to 
quantify neutralising antibodies against Zika virus and 
dengue virus in both the child and her mother. CT (with 
a 64-section CT scanner [Philips Brilliance, UK]) and 
MRI (with a 1.5-T Espree [Siemens Healthcare, 
Germany]) were done to assess whether the child’s 
neurological damage was consistent with congenital Zika 
Figure 1: Confirmed Angola-associated cases of Zika virus infection
Cases in travellers from Angola identified elsewhere are shown above the line,10,11,28 whereas locally identified cases are shown below the line. Dates and locations in bold are the data and place of birth for 
the girls with microcephaly, and the date and location of sampling for other cases. Cycle threshold values for cases confirmed by real-time RT-PCR are also shown. RT-PCR=reverse transcription PCR. 
April, 2017, Taiwan (Taiwan Centers 
for Disease Control, 2017)
20-year-old male returning traveller with
fever, headache, fatigue, rash, and pain in
early April, 2017.
Angola from mid March to early April, 2017.
Infection confirmed in April, 2017.
May 25, 2017, Bengo
44-year-old woman with conjunctivitis,
rash, fever, headache, allergy,
and influenza-like symptoms
on May 23.
No travel outside Bengo.
PCR cycle threshold value 31.
September, 2016, France
(WHO South Africa, 2017)
41-year-old male returning traveller
with rash, arthralgia, myalgia, and
headache Sept 14. 
Luanda and  Benguela, August–Sept 5.






Confirmed by serology or unspecified
Confirmed by RT-PCR
Confirmed by RT-PCR and sequencing
Initiation of Zika RT-PCR testing in Angola
Identified through Angolan Ministry 
of Health routine surveillance
*
June 15, 2017, Luanda
17-year-old girl with HIV
(not identified by routine surveillance).
Unknown travel history.
PCR cycle threshold value 30.
Oct 26, 2017, Portugal
Girl with severe microcephaly.
33-year-old mother normally resident in Luanda.
Travelled to Lubango (Huíla) during
February–May, 2017.
Mother was IgM negative and IgG positive.
PCR cycle threshold value 37 (infant urine
1 day after birth). 
Dec 26, 2016, Luanda
14-year-old boy with fever,
asthenia, headache, rash,
vomiting, and jaundice on
Dec 25.
No travel for 3 weeks.
PCR cycle threshold value 29.
Jan 11, 2017, Bengo
29-year-old woman.
Gave birth to a stillborn
infant by caesarean







Early August 2017, Moxico, Angola
(reported from Brazil;
November, 2018)
Girl with severe microcephaly.
Mother had rash in January, 2017
while in Luanda (during pregnancy).
Travelled to Brazil in November, 2018 
(no previous travel outside Angola). 
Mother and infant IgG positive.
* * *
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syndrome. Ethical approval for this aspect of the study 
was granted by the local internal review board at IPESQ 
(Campina Grande, Brazil; 52888616.4.0000.5693). The 
mother of the child with microcephaly provided written 
consent on behalf of herself and her child.
Role of the funding source
The funders of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding authors had full access to all 
the data in the study and had final responsibility for the 
decision to submit for publication.
Results
Between December, 2016, and October, 2018, serum 
samples were collected from 54 patients with sus pected 
Zika virus, who were notified to the Angola Ministry of 
Health after clinical examination (appendix p 12).
Three cases of Zika virus infection were detected by 
routine surveillance using real-time RT-PCR (figure 1). 
The earliest case detected by routine Ministry of 
Health surveillance was identified in December, 2016, 
(immediately after real-time RT-PCR surveillance was 
initiated), and the latest in May, 2017. Data for the time 
between presence of symptoms and collection of the 
sample were available for two positive cases (figure 1). 
Although suspected cases of Zika virus infection were 
reported across Angola (figure 2A), all confirmed cases of 
Zika virus infection were residents of, or had travelled to 
or through, Luanda or the neighbouring province of 
Bengo (figures 1, 2A).
One additional case of acute Zika virus infection (from 
June, 2017) was detected by screening an unrelated 
archive of serum samples from people with HIV using 
real-time RT-PCR (figure 1; appendix p 12). This person 
had no history of recent travel outside Luanda province.
No additional positive cases of Zika virus were detec-
ted among samples collected during 2018 from the 
336 patients with suspected dengue virus or 
chikungunya virus infections. Of the 51 people with 
suspected Zika virus infection who tested negative for 
Zika virus, three tested positive for dengue virus 
infection, and seven tested positive for chikungunya 
virus infection. No samples were co-infected with more 
than one virus.
We did genomic sequencing and phylogenetic analyses 
of three Zika virus infections acquired in Angola: 
from one patient notified for suspected Zika virus acute 
infection, the asymptomatic person detected in the 
sample from the trial of people with HIV, and a neonate 
with microcephaly who was previously identified in 
Portugal.10 Figure 1 shows additional information about 
these three cases, including reported symptoms and 
travel history (appendix p 13).
Figure 2: Spatial distribution of suspected cases of acute Zika virus infection and microcephaly (A) and dates of suspected cases of microcephaly (B) in Angola
(B) Dates of birth, rather than report dates, are shown, so only infants for whom the date of birth was recorded were included (73 [96%] of 76 cases). Arrows mark the 
month of birth of the two cases of microcephaly independently identified and confirmed in Brazil (August, 2017), and Portugal (October, 2017).10 Orange dots on the 
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Maximum likelihood phylogenies suggested that the 
three Zika virus strains formed a single, well supported 
monophyletic clade within the Asian lineage of Zika 
virus that is circulating in the Americas (bootstrap score 
0·96; appendix p 9). Thus, the Zika virus outbreak in 
Angola probably resulted from a successful introduction 
of the virus followed by autochthonous transmission 
within Angola.
Our phylogenetic analyses suggest that Zika virus was 
probably introduced to Angola from Brazil (figure 3), 
possibly from the southeast of Brazil, where the most 
closely related virus to the Angola Zika virus clade 
was sampled (accession number KY559016; posterior 
prob ability 0·99). The estimated date of the most 
recent common ancestor of the Angola Zika virus 
sequences is June, 2016 (Bayesian 95% credible interval 
January–October, 2016; figure 3). The date of divergence 
of the Angolan Zika virus cluster from the most closely 
related Brazilian Zika virus sequence was July, 2015 
(Bayesian 95% credible interval February, 2015–February, 
2016; figure 3). Phylogenetic estimates therefore sug gest 
that Zika virus was introduced to Angola from Brazil 
between July, 2015, and June, 2016. Given that the last 
positive case was identified in October, 2017 (figure 1), 
Zika virus therefore probably circulated in Angola for 
17–28 months.
Our analysis of global mobility data showed that 80% of 
all air passengers who travelled to Angola from countries 
reporting Zika virus infections began their journey in 
Brazil, whereas only 0·15% began their journey in Cape 
Verde. Crucially, Brazil was the only country that was 
highly connected to Angola via air travel and had a high 
frequency of cases of Zika virus infection (figure 4). 
Furthermore, the climatic suitability for Aedes spp 
mosquito-borne viral transmission is more synchronous 
between Angola and Brazil than between Angola and Cape 
Figure 3: Phylogenetic analysis of the introduction of Zika virus to Angola
(A) Maximum clade credibility phylogeny, estimated from complete and near-complete Zika virus genomes with a molecular clock phylogenetic approach. Branch colours indicate the most 
parsimonious locations of ancestral lineages. Triangular clades represent larger groups of sequences that have been collapsed for visual clarity. (B) Expansion of the clade containing the Angolan Zika 
virus (red) and closely related sequences from the Americas (blue and yellow). Clade posterior probabilities are shown at well supported nodes.
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Verde (appendix p 10). Thus, genomic, epidemiological, 
mobility, and climatic data support the hypothesis that 
Zika virus was introduced directly to Angola from Brazil.
Serum samples were collected from 76 infants with 
suspected microcephaly between Jan 1, 2017, and 
Nov 31, 2018 (median time of sample collection 24 days 
after birth [IQR 4–85; range 0–315 days]; figure 2; 
appendix p 7). The number of neonates with suspected 
microcephaly peaked around November, 2017, and 
subsequently declined (figure 2B). This peak occurred 
several months after PCR-confirmed cases of acute Zika 
virus infection were detected in Angola (figure 2B). Head 
circumference was not recorded for any of the 14 suspected 
cases of microcephaly that were detected in 2017, but was 
recorded for 53 (85%) of the 62 suspected cases reported 
in 2018. All infants with suspected microcephaly for 
whom head circumference was measured had head 
circumferences that were at least two SDs below expected 
by age according to WHO’s child growth standards 
(appendix p 11), regardless of time of identification after 
birth.  Additional clinical assessments were not typically 
reported. Serum samples were also collected from 
24 mothers.
No samples from infants with suspected microcephaly 
or their mothers were positive for Zika virus infection 
as measured by real-time RT-PCR. Conversely, none of the 
eight infants in whom serological testing was done showed 
evidence of recent infection with other ToRC pathogens. 
Thus, the cause of microcephaly was uncertain.
The girl with microcephaly who was born in Angola but 
presented in Brazil on whom we did extensive 
investigations had a head circumference at birth of 29 cm 
(Z score –3·6) according to her mother. Clinical 
examination suggested severe and disproportionate 
microcephaly. The 21-year-old mother was a long-term 
resident of Moxico province, but travelled to Luanda 
during the second and third months of pregnancy and 
developed a rash during this visit (week 10 of pregnancy; 
January, 2017). Diagnostic surveillance data showed that 
Zika virus was present in Luanda and Bengo province 
when she had this rash (figure 1). The girl with 
microcephaly was born in August, 2017, coincident with 
the increase in neonates with suspected microcephaly 
reported in Angola (figure 2).
CT and MRI, which were done when the child was age 
15 months, confirmed microcephaly via reduced cerebral 
volume, and showed abnormalities consistent with 
congenital Zika syndrome that had been noted in Brazil 
and elsewhere—eg, calcification areas, ventriculomegaly, 
brainstem hypoplasia, dysgenesis of the cerebellum, and 
pachygyria (figure 5).29 At age 15 months, the child had a 
head circumference of 37 cm (Z score –6·3). She was IgG 
negative for both dengue virus and Zika virus by ELISA, 
but weakly positive for Zika virus neutralising antibodies 
according to the specific plaque reduction neutralisation 
test (titre=40). Her mother was strongly IgG positive for 
Zika virus by ELISA, and had a weak dengue virus IgG 
response. A specific plaque reduction neutralisation test 
confirmed the strong neutralising antibody response in 
the mother (titre=1280). These findings strongly suggest 
that the mother had been previously infected with Zika 
virus. Both the mother and child had negative dengue 
Figure 4: Factors affecting the likelihood of introduction of Asian lineage Zika virus to Angola
The 11 countries shown are those with the seven highest median passenger numbers and number of cases of Zika 
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Figure 5: Brain CT and MRI scans of an Angolan child with microcephaly
(A) Compensatory ventriculomegaly and calcification areas in the subcortical region are shown by green arrows. 
In (B) and (C), calcification in the basal ganglia is shown by the green arrows. (D) Brainstem hypoplasia. 
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virus neutralising antibody responses by specific plaque 
neutralisation test assay (titre ≤10). The long-term 
outcomes for this child included delayed neurological and 
development status (on the Bayley Scales of Infant and 
Toddler Development) and epileptic spasms—findings 
common in cases of congenital Zika syndrome.
Discussion
In this multi-component outbreak investigation, we 
characterised the first known outbreak of Asian lineage 
Zika virus in continental Africa. Although surveillance, 
genetic, and clinical data were individually scarce, 
together these independent lines of evidence provide a 
cohesive picture of the outbreak of Zika virus infection in 
Angola. We report data for five cases of Zika virus 
infection between December, 2016, and October, 2017, 
and confirmed by real-time RT-PCR. The three Zika virus 
genomes that we sequenced represent the first Asian 
lineage genomes reported from Africa, and the first 
genome isolated from a case with Zika-virus-associated 
microcephaly in Africa. Our phylogenetic analyses 
showed that Zika virus was probably introduced to Angola 
from Brazil and then circulated for 17–28 months. Finally, 
our serological investigations in one mother–child pair 
supported the view that the Zika virus outbreak caused 
microcephaly in Angola.
Phylogenetic analysis showed that the three Angolan 
Zika virus genomes formed a single clade with a common 
ancestor in June, 2016. These findings suggest either a 
single successful introduction that initiated local Zika 
virus transmission in Angola that continued until at least 
June, 2017, or recurrent but later introduction to Angola of 
viruses belonging to a specific lineage present in Brazil. 
The latter explanation is much less likely, because it is 
improbable that three or more independent introductions 
of Zika virus to Angola would belong to only one of the 
many different lineages that circulated contemporaneously 
in Brazil.13 Thus, Zika virus could have circulated in 
Angola for at least 3 months before a case was first 
detected in a returning traveller,11 and for at least 6 months 
before a local case was detected. Similar or longer periods 
of cryptic Zika virus transmission have been reported 
in the Americas13 and attributed partly to difficulties in 
identifying clinical cases when infections are asymp- 
tomatic or mildly symptomatic.15
Zika virus probably circulated in Angola for 
17–28 months—sustained transmission that implies that 
the outbreak was substantially larger than the small 
number of cases detected by surveillance. Low case 
detection has been reported previously (eg, in Cape Verde, 
where less than 3% of the estimated number of infected 
individuals were suspected to have Zika virus infection).7 
Retrospective screening of stored samples could help to 
establish the magnitude and duration of undetected Zika 
virus transmission in Angola since 2015.
Zika virus was probably introduced to Angola from 
Brazil, but we cannot rule out the possibility that it could 
have spread to Angola from affected locations where 
genomic data are unavailable. However, data for human 
flight mobility and the global incidence of Zika virus 
support our phylogenetic conclusion that Brazil is the 
most likely origin of the Angolan outbreak. Transmission 
of mosquito-borne viruses between these two countries 
was previously shown by the spread of chikungunya virus 
from Angola to Brazil in 2014.30 Notably, both African 
countries with confirmed Asian-lineage Zika virus 
(ie, Angola and Cape Verde) have regular air connectivity 
with Brazil,5 which likely reflects the close historical, 
cultural, and linguistic links between these countries. Of 
all African countries, Angola received the largest number 
of travellers from Zika-virus-affected countries in the 
Americas.5 The introduction of Zika virus to Angola 
therefore underscores the need to coordinate viral 
surveillance strategies across countries that share high 
human interconnectivity and similar vector-borne 
transmission potential, irrespective of their distance apart.
The Asian lineage of Zika virus that circulated in 
Angola caused microcephaly in Brazil and elsewhere.31 In 
our study, none of the 76 infants with suspected 
microcephaly whom we tested were positive for Zika 
virus infection by real-time RT-PCR. However, this 
finding does not prove that all these infants did not have 
previous Zika virus infection. Zika viraemia declines to 
undetectable levels in blood within 11 days of symptom 
onset in adults.32 The infant samples tested here were 
collected a median of 24 days after birth, and infection 
could have occurred early during pregnancy. The 
occurrence of several, large dengue virus outbreaks in 
Angola33,34 meant commercial ELISAs could not be used 
to serologically diagnose Zika virus, because these assays 
frequently fail to accurately discriminate between 
previous exposure to dengue virus and to Zika virus.27 The 
cause and clinical severity of the suspected cases of 
microcephaly identified by routine surveillance by the 
Angola Ministry of Health that we report here remain 
unclear.
To date, there have been only two confirmed reports of 
microcephaly in which the mother of the infant lived in 
Angola: one infant who was identified clinically in this 
study, and one who was identified by Sassetti and 
colleagues10 for whom we sequenced the infecting Zika 
virus genome. Both infants had brain abnormalities 
consistent with congenital Zika syndrome. The mother of 
the child identified in our study had a strong Zika-virus-
positive response on the specific plaque neutralisation test 
assay, by contrast with her child, who had only a weakly 
positive response. This result is consistent with 
intrauterine Zika virus exposure because infants typically 
lose maternally acquired IgG antibodies during the 
6–12 months after birth,35 and the child was 15 months old 
when tested. Data for the two confirmed cases therefore 
strongly suggest that Zika virus has caused microcephaly 
in Angola. Both infants were born at approximately the 
same time as the rise in suspected microcephaly cases 
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identified independently by the Angolan Ministry of 
Health.
We present several complementary lines of evidence 
that together form a cohesive insight into the origins 
and effects of Zika virus in Angola. Despite the overall 
concordance of these different data streams, several 
aspects of the study have additional limitations that 
should be considered. First, the proportion of diagnostic 
samples that were positive for Zika virus infection by 
real-time RT-PCR in Angola is probably an underestimate 
of the true numbers of infections. Suboptimum sample 
transport and lack of information about the date of onset 
of symptoms mean that samples could have degraded 
before testing or been collected after viraemia was no 
longer detectable.32 Second, the spatiotemporal dis-
tributions of notified suspected cases of microcephaly 
and Zika virus were very difficult to interpret with 
confidence because the total number of reported cases 
was low, the consistency of case detection and reporting 
were probably highly variable, and the intensity of 
surveillance efforts has changed over time. Gestational 
age was not recorded for any suspected cases of 
microcephaly, and head circumference was not reported 
for some notified cases, and thus the severity of 
microcephaly was difficult to establish. The absence 
of serological testing for Zika virus and other STORCH 
pathogens (ie, syphilis, Toxoplasma gondii, rubella, 
cytomegalovirus, herpes simplex, and others) in infants 
with suspected microcephaly makes the cause of these 
cases difficult to establish. Widespread, routine 
screening of pregnant women for STORCH pathogen 
infections and follow-up of children born with brain 
abnormalities would improve understanding of the 
extent and causes of birth defects in Africa.
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